08357

0.1360.00%
CS

Cher Sen Tan

Executive Chairman & Compliance Officer

Dr. Cher Sen Tan, also known as Alan, is the Chairman of Republic Healthcare Ltd. and has been its Executive Director since January 3, 2018 and is its Compliance Officer since September 30, 2020. Dr. Tan is primarily responsible for the overall strategic planning, management and business development. Dr. Tan has experience in the healthcare and medical industry and has extensive experience in marketing and management in the healthcare industry. From 2001 to 2002, he worked as a house officer and medical officer in Singapore Healthcare Services, Ang Mo Kio Community Hospital, KK Women’s and Children’s Hospital, National University Hospital and Alexandra Hospital where he was principally responsible for medical care of in patients and out patients. From 2002 to 2006, Dr. Tan held various management and administrative positions in Singhealth Cluster, Singapore General Hospital and National Heart Centre, where he contributed to research ethics, doctors training programme, staffing, policy development and other general operational aspects of the hospital. From 2006 to 2007, Dr. Tan worked as Regional Medical Advisor, Asia-Pacific region in Schering AG (now known as Bayer Schering Pharma) where he was involved in the development, launch and marketing of various medical products as a medical expert for gynaecology and andrology. From 2008 to 2010, Dr. Tan worked as the Regional Head of Medical Affairs and Oncology in Invida Pharmaceutical Holdings Pte. Ltd. where he was primarily responsible for leading the medical department in day-to-day activities and overseeing the marketing and regional business development for major oncological medicines. Based on his knowledge and skills in the medical profession, he founded Repub Healthcare Group in 2010. In March 2017, he was appointed as a non-executive director of Concord Healthcare Singapore Pte. Ltd., which is a member of the group of Concord Medical Services Holdings Limited (a company listed on the National Association of Securities Dealers Automated Quotation with stock code: CCM). Since May 2017, Dr. Tan was an indirect sole shareholder and one of the directors of the KL Company up to 15 November 2017 and 17 October 2017, respectively. Dr. Tan graduated from National University of Singapore in July 2001 with a Bachelor of Medicine degree and a Bachelor of Surgery degree. He further obtained a degree of Master of Business Administration (Information Technology Management) from University of Leicester, United Kingdom in January 2009. He became a full registration member of the SMC and the General Medical Council in the United Kingdom in May 2002 and November 2003, respectively.

Positions